The Thai Food and Drug Administration (Thai FDA) collaborates with the Department of International Trade Promotion (DITP) and the Department of Intellectual Property (DIP) to propel the export of Thai health products to the global market in a systematic and sustainable manner.

Today (8 September 2025), at the Main Conference Room, 10th Floor, OSSC Building, Thai FDA, Dr. Surachoke Tangwiwat, Secretary-General of the Thai FDA, announced the signing of two Memorandum of Understanding (MOUs): an MOU with DITP on promoting the export of Thai health products to global markets; and an MOU with DIP on strengthening patent capabilities and regulatory support to foster the development of Thailand’s health-product industry. The shared goal is to elevate Thai health products to be competitive on the global stage. In addition to ensuring quality, standards, and safety in line with international benchmarks—thereby building confidence among consumers both domestically and internationally—the Thai FDA also plays a key role in supporting health-product entrepreneurs to compete effectively.
Ms. Sunanta Kangwankulkij, Director-General of DITP, added that cooperation with the Thai FDA to drive the export of Thai health products to global markets is based on three key strategies: (1) building confidence through the Thai FDA’s proactive regulatory oversight, (2) market activation and access to overseas demand by DITP through proactive “market-entry platforms” such as business negotiations, trade fairs, andThai-brand campaigns and (3) integrated cooperation between DITP and the Thai FDA to define priority health-product targets, to select and strengthen entrepreneurs to meet international standards while preserving Thai identity—thereby extending and expanding sustainable trade opportunities in global markets
Ms. Nusara Kanjanakul, Director-General of DIP, added that this collaboration marks an important step in advancing Thailand’s innovation system through integration and data-sharing between the two agencies. It will foster the development of health-sector innovation, while also serving as a platform to build awareness and a correct understanding of respect for intellectual property rights among all stakeholders. This will be carried out through the DIP’s four core mandates:(1) Creation—encouraging creativity (2) Commercialization—promoting the commercial use of intellectual property (3) Protection—providing intellectual property protection, and (4) Enforcement—promoting the enforcement of intellectual property rights domestically and internationally
The Secretary-General concluded that the signing of these two MOUs represents an important milestone for the Thai FDA, DITP, and DIP in strengthening cooperation and integrating our work—from building an conducive ecosystem for the development of Thai health products and expanding to export—in order to support Thai entrepreneurs in enhancing their competitiveness and capacity to develop products and expand into global markets effectively, thereby helping drive sustainable growth of Thailand’s health-product industry.

**************************
Published on 8 September 2025